<DOC>
	<DOCNO>NCT02722122</DOCNO>
	<brief_summary>This study evaluate Safety , Tolerability , Pharmacokinetics Exploratory Efficacy Parameters AIR DNase™in Patients Cystic Fibrosis previously treat Pulmozyme® .</brief_summary>
	<brief_title>Study Evaluate Safety , Tolerability , Pharmacokinetics Exploratory Efficacy Parameters AIR DNase™in Patients With Cystic Fibrosis Previously Treated With Pulmozyme®</brief_title>
	<detailed_description>This proof-of-concept , open label study , evaluate safety , tolerability , pharmacokinetics exploratory efficacy 2.5 mg AIR DNase TM administer daily 28 day via inhalation Cystic Fibrosis subject previously treat Pulmozyme® . This multicenter study conduct approximately 10 site enroll 15 subject .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Main 1 . Age ≥ 12 year age ( inclusive ) time screen 2 . Weight ≥ 36 kg 3 . Prior confirm diagnosis CF 4 . At least 4 month treatment Pulmozyme® prior screen . 5 . The subject medically stable least one month prior screen visit . 6 . Stable inhaled regimen either : antibiotic , steroid , hypertonic saline least four month prior screen visit . 7 . FEV1 &gt; 40 % &lt; 90 % FVC ≥ 40 % predict normal age , gender , height screen . 8 . Female male subject whose copartner child bear potential must agree use two medically acceptable method contraception , include rhythm method . 9 . Be willing able adhere study visit schedule protocol requirement 10 . Be willing able provide voluntary write informed consent Main 1 . Has history lung transplantation . 2 . Female subject pregnant lactating . 3 . History severe unexplained adverse reaction aerosol delivery medicinal product . 4 . History presence hypersensitivity reaction inhale protein . 5 . Participation another clinical trial within 60 day prior screen . 6 . Presence medical , emotional , behavioral psychological condition judgment Investigator would interfere subject 's safety compliance requirement study . 7 . Have positive serology human immunodeficiency virus ( HIV ) Hepatitis B Hepatitis C infection .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Cystic Fibrosis</keyword>
	<keyword>CF</keyword>
	<keyword>AIR DNase™</keyword>
	<keyword>Digestive System Diseases</keyword>
	<keyword>Genetic Diseases , Inborn</keyword>
	<keyword>Infant , New born , Diseases</keyword>
	<keyword>Lung disease</keyword>
	<keyword>Pancreatic Diseases</keyword>
	<keyword>Respiratory Tract Diseases</keyword>
</DOC>